SCHEMBL3206574

SCHEMBL3206574

NC(=O)c1nc(-c2ccco2)cs1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 8/20 0.60
HSD17B10 Q99714 5/20 0.60
ALDH1A1 P00352 7/20 0.51
MEN1 O00255 6/20 0.51
KMT2A Q03164 6/20 0.51
RAB9A P51151 5/20 0.51
NPC1 O15118 4/20 0.51
PKM P14618 2/20 0.51
ALOX15 P16050 2/20 0.51
TSHR P16473 1/20 0.51
KDM4E B2RXH2 6/20 0.49
HPGD P15428 5/20 0.49
LMNA P02545 3/20 0.49
TDP1 Q9NUW8 3/20 0.49
SMN1; SMN2 Q16637 2/20 0.49
RECQL P46063 2/20 0.49
MCL1 Q07820 2/20 0.49
CYP19A1 P11511 1/20 0.49
HTT P42858 2/20 0.48
GFER P55789 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3065254 0.85 MAPT (0.57) MAPTHSD17B10ALDH1A1MEN1KMT2A
SCHEMBL1677400 0.84 MAPT (0.60) MAPTHSD17B10ALDH1A1MEN1KMT2A
SCHEMBL1677361 0.77 MEN1 (0.61) MAPTHSD17B10ALDH1A1MEN1KMT2A
SCHEMBL1677347 0.77 L3MBTL1 (0.56) MAPTHSD17B10ALDH1A1MEN1KMT2A
SCHEMBL653613 0.75 MAPT (1.00) MAPTHSD17B10ALDH1A1MEN1KMT2A
SCHEMBL9829656 0.75 MAPT (0.53) MAPTHSD17B10ALDH1A1MEN1KMT2A
SCHEMBL1677251 0.75 NPC1 (0.60) MAPTHSD17B10ALDH1A1MEN1KMT2A
SCHEMBL168593 0.75 ALDH1A1 (0.56) MAPTHSD17B10ALDH1A1MEN1KMT2A
SCHEMBL21366246 0.74 MAPT (0.58) MAPTHSD17B10ALDH1A1MEN1KMT2A
SCHEMBL22761299 0.73 MAPT (0.64) MAPTHSD17B10ALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010027564-A2 AMIDO ANTI-VIRAL COMPOUNDS, COMPOSITIONS, AND METHODS OF USE GLAXOSMITHKLINE LLC (US) 2010-03-11 WO claimed
US-20100061960-A1 Amido Anti-Viral Compounds, Compositions, And Methods Of Use SCHMITZ FRANZ ULRICH 2010-03-11 US claimed
US-20100061960-A1 Amido Anti-Viral Compounds, Compositions, And Methods Of Use SCHMITZ FRANZ ULRICH 2010-03-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100061960-A1 Amido Anti-Viral Compounds, Compositions, And Methods Of Use HAVCR2, OAT, MAVS MAPT 21/4885HSD17B10 4050/4885ALDH1A1 4853/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.